Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
Research institute in Greenslopes, Queensland
Lower Lobby Level Administration Building Greenslopes Private Hospital, Newdegate St, Greenslopes QLD 4120
About Gallipoli Medical Research Foundation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
EMD Serono Research & Development Institute, Inc.
2
Gilead Sciences
2
Hoffmann-La Roche
2
Pfizer
2
Arcus Biosciences, Inc.
1
Assembly Biosciences
1
Beyond Air Inc.
1
Bristol-Myers Squibb
1
Insmed Incorporated
1
Intercept Pharmaceuticals
1
Inventiva Pharma
1
Clinical Trials at Gallipoli Medical Research Foundation
During the past decade, Gallipoli Medical Research Foundation conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
2012-06-01
2014-12-01
Completed
534
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
2013-11-05
2026-08-25
Active, not recruiting
1,499
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
2015-08-31
2022-05-23
Completed
600
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
2015-09-22
2025-09-01
Active, not recruiting
2,480
Avelumab in First-line NSCLC (JAVELIN Lung 100)
2015-10-29
2022-12-31
Active, not recruiting
1,214
Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis
2017-10-31
2019-12-12
Completed
256
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gallipoli Medical Research Foundation" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "Gilead Sciences" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arcus Biosciences, Inc."
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gallipoli Medical Research Foundation"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Gallipoli Medical Research Foundation
According to Clinical.Site data, the most researched conditions in "Gallipoli Medical Research Foundation" are
"Melanoma" (3 trials), "Bladder Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Merkel Cell Carcinoma" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Gallipoli Medical Research Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Gallipoli Medical Research Foundation
Most popular intervention types in "Gallipoli Medical Research Foundation" are "Drug" (14 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Nivolumab" (2 trials), "ABI-H2158" (1 trials), "Avelumab" (1 trials) and "Avelumab Weekly" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gallipoli Medical Research Foundation
The vast majority of trials in "Gallipoli Medical Research Foundation" are
17 trials for "All" genders.
Clinical Trials Status at Gallipoli Medical Research Foundation
Currently, there are NaN active trials in "Gallipoli Medical Research Foundation".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Gallipoli Medical Research Foundation,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Gallipoli Medical Research Foundation, 4 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".